Literature DB >> 7007487

Anthrax. William Smith Greenfield, M.D., F.R.C.P., Professor Superintendent, the Brown Animal Sanatory Institution (1878-81). Concerning the priority due to him for the production of the first vaccine against anthrax.

W D Tigertt.   

Abstract

The purpose of this paper is to draw attention to the fact that W. S. Greenfield, working at the Brown Animal Sanatory Institution in London, prepared an effective vaccine against anthrax and described his results some months before the experiment of Pasteur at Pouilly-le-fort. Partly through lack of financial support and partly due to opposition by the antivivisectionists, Greenfield was forced to confine his experiments to a small number of animals, but his results were nevertheless conclusive. He showed that by continuous subculture in a fluid medium that the anthrax bacillus progressively lost its virulence, until it was harmless even to the most susceptible animal, the mouse. The injection of suitably attenuated organisms into cattle rendered them immune to the subsequent injection of virulent anthrax bacilli. Greenfield's work has been overlooked or neglected, and he has never received the credit due him. It is only fitting that his work should be acknowledged in the centenary of the year in which it was described. The following account is composed primarily of quotations from his published papers. For additional information on Greenfield, reference may be made to the series of papers by Wilson (1979 a, b). It may be pointed out that the method of attenuating the virulence of bacilli recorded by Pasteur in relation to the bacillus of fowl cholera was, like that of anthrax vaccine, anticipated by Greenfield.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7007487      PMCID: PMC2134029          DOI: 10.1017/s0022172400063488

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  1 in total

1.  The Brown Animal Sanatory Institution.

Authors:  G Wilson
Journal:  J Hyg (Lond)       Date:  1979-08
  1 in total
  8 in total

1.  [Anthrax. The growing danger].

Authors:  H Schorle
Journal:  Pathologe       Date:  2002-05       Impact factor: 1.011

2.  Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease.

Authors:  Miriam A Balderas; Chinh T Q Nguyen; Austen Terwilliger; Wendy A Keitel; Angelina Iniguez; Rodrigo Torres; Frederico Palacios; Celia W Goulding; Anthony W Maresso
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

3.  Evidence for plasmid-mediated toxin production in Bacillus anthracis.

Authors:  P Mikesell; B E Ivins; J D Ristroph; T M Dreier
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

Review 4.  Anthrax vaccination strategies.

Authors:  Robert J Cybulski; Patrick Sanz; Alison D O'Brien
Journal:  Mol Aspects Med       Date:  2009-09-01

5.  An attenuated strain of Bacillus anthracis (CDC 684) has a large chromosomal inversion and altered growth kinetics.

Authors:  Richard T Okinaka; Erin P Price; Spenser R Wolken; Jeffrey M Gruendike; Wai Kwan Chung; Talima Pearson; Gary Xie; Chris Munk; Karen K Hill; Jean Challacombe; Bruce E Ivins; James M Schupp; Stephen M Beckstrom-Sternberg; Arthur Friedlander; Paul Keim
Journal:  BMC Genomics       Date:  2011-09-30       Impact factor: 3.969

6.  Germ theories of disease and British veterinary medicine, 1860-1890.

Authors:  M Worboys
Journal:  Med Hist       Date:  1991-07       Impact factor: 1.419

Review 7.  Cellular and physiological effects of anthrax exotoxin and its relevance to disease.

Authors:  David E Lowe; Ian J Glomski
Journal:  Front Cell Infect Microbiol       Date:  2012-06-01       Impact factor: 5.293

8.  A Bacillus anthracis Genome Sequence from the Sverdlovsk 1979 Autopsy Specimens.

Authors:  Jason W Sahl; Talima Pearson; Richard Okinaka; James M Schupp; John D Gillece; Hannah Heaton; Dawn Birdsell; Crystal Hepp; Viacheslav Fofanov; Ramón Noseda; Antonio Fasanella; Alex Hoffmaster; David M Wagner; Paul Keim
Journal:  MBio       Date:  2016-09-27       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.